.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Baxter
Teva
US Army
Citi
Healthtrust
Daiichi Sankyo
Argus Health
Cipla
McKinsey

Generated: July 25, 2017

DrugPatentWatch Database Preview

LETROZOLE Drug Profile

« Back to Dashboard

Which patents cover Letrozole, and what generic Letrozole alternatives are available?

Letrozole is a drug marketed by Apotex Inc, Indicus Pharma, Jiangsu Hengrui Med, Accord Hlthcare, Impax Labs, West-ward Pharms Int, Lannett Holdings Inc, Natco Pharma Ltd, Sun Pharm Inds Ltd, Teva Pharms, Vintage Pharms Llc, Mylan, Dr Reddys Labs Ltd, Fresenius Kabi Oncol, Actavis Totowa, Hikma Pharms, Synthon Pharms, and Kremers Urban Pharms. and is included in eighteen NDAs.

The generic ingredient in LETROZOLE is letrozole. There are twenty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the letrozole profile page.

Summary for Tradename: LETROZOLE

Patents:0
Applicants:18
NDAs:18
Suppliers / Packagers: see list20
Bulk Api Vendors: see list91
Clinical Trials: see list333
Patent Applications: see list6,923
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LETROZOLE at DailyMed

Pharmacology for Tradename: LETROZOLE

Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
LETROZOLE
letrozole
TABLET;ORAL091303-001Apr 19, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Kremers Urban Pharms
LETROZOLE
letrozole
TABLET;ORAL091098-001Jun 3, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
LETROZOLE
letrozole
TABLET;ORAL202048-001Oct 29, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
LETROZOLE
letrozole
TABLET;ORAL090934-001Jun 3, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
LETROZOLE
letrozole
TABLET;ORAL078190-001Dec 24, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Merck
Cantor Fitzgerald
AstraZeneca
Novartis
Dow
Federal Trade Commission
Harvard Business School
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot